Do COX-2 inhibitors reduce renal fibrosis?
Harding
Pamela
P
D000450:Aldosterone / Q000652:urine; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D000068579:Celecoxib; D003404:Creatinine / Q000097:blood; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006978:Hypertension, Renovascular / Q000378:metabolism* / Q000503:physiopathology*; D007527:Isoenzymes / Q000187:drug effects* / Q000378:metabolism*; D007668:Kidney / Q000098:blood supply* / Q000378:metabolism / Q000502:physiology*; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000187:drug effects* / Q000378:metabolism*; D011720:Pyrazoles; D012083:Renin / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D013599:Systole / Q000187:drug effects; D014508:Urea / Q000097:blood
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D011720:Pyrazoles; D013449:Sulfonamides; D000450:Aldosterone; D014508:Urea; D003404:Creatinine; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D012083:Renin; D000068579:Celecoxib